InvestorsObserver

MED Medifast Inc

$20.14 $-0.58 (-2.80%)
15 Minute Delayed Price Enable Real-Time Price
Overall

MED Stock Analysis Overview

What this means: Medifast Inc (MED) gets a very poor rank from InvestorsObserver. Our comprehensive analysis of fundamental and technical factors gives MED a rank of 17. Our methodology considers analysis of the company's financial situation and how it has traded recently. MED rank of 17 means that it ranks below 83% of stocks.

Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.

View Sample Report
Fundamental PREMIUM

MED Fundamental Analysis

Who this matters to: The Fundamental Ranking considers the health of the underlying company. It is best used by longer-term buy-and-hold investors.

Upgrade to Premium to unlock Fundamental Ranking

Short-Term Technical PREMIUM

MED Short-Term Technical Analysis

Who this matters to: The Short-Term Technical Ranking evaluates a stock’s trading over the past month. This is most useful for short- to medium-term stock and option traders.

Upgrade to Premium to unlock Short-Term Technical Ranking

Long-Term Technical PREMIUM

MED Long-Term Technical Analysis

Who this matters to: The Long-Term Technical Ranking is a good gauge of how a stock has traded over the past several months. This is useful for medium to long-term stock and option traders.

Upgrade to Premium to unlock Long-Term Technical Ranking

Analyst Ranking PREMIUM

MED Analyst Ranking

Who this matters to: Analyst Ranking shows you which stocks Wall Street analysts like the most. Since analysts build valuation models, this is most useful for medium to long-term investors who are interested in a valuation-based approach.

Upgrade to Premium to unlock Analyst Ranking Analysis

Valuation PREMIUM

MED Valuation Ranking Analysis

Who this matters to: Valuation Ranking is most-useful for value-focused investors who plan to hold a stock for the long term.

Upgrade to Premium to unlock Valuation Ranking

Stock Sentiment PREMIUM

MED Stock Sentiment Analysis

Who this matters to: Sentiment Rank looks at the past five trading days. This is our shortest-term evaluation and is best used by people with a very short horizon.

Upgrade to Premium to unlock Stock Sentiment Ranking

MED Stock Analysis Overview

What this means: Medifast Inc (MED) gets a very poor rank from InvestorsObserver. Our comprehensive analysis of fundamental and technical factors gives MED a rank of 17. Our methodology considers analysis of the company's financial situation and how it has traded recently. MED rank of 17 means that it ranks below 83% of stocks.

Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.

Create a FREE account to see full MED report

MED Fundamental Analysis

Who this matters to: The Fundamental Ranking considers the health of the underlying company. It is best used by longer-term buy-and-hold investors.

Upgrade to Premium to unlock Fundamental Ranking

MED Short-Term Technical Analysis

Who this matters to: The Short-Term Technical Ranking evaluates a stock’s trading over the past month. This is most useful for short- to medium-term stock and option traders.

Upgrade to Premium to unlock Short-Term Technical Ranking

MED Long-Term Technical Analysis

Who this matters to: The Long-Term Technical Ranking is a good gauge of how a stock has traded over the past several months. This is useful for medium to long-term stock and option traders.

Upgrade to Premium to unlock Long-Term Technical Ranking

MED Analyst Ranking

Who this matters to: Analyst Ranking shows you which stocks Wall Street analysts like the most. Since analysts build valuation models, this is most useful for medium to long-term investors who are interested in a valuation-based approach.

Upgrade to Premium to unlock Analyst Ranking Analysis

MED Valuation Ranking Analysis

Who this matters to: Valuation Ranking is most-useful for value-focused investors who plan to hold a stock for the long term.

Upgrade to Premium to unlock Valuation Ranking

MED Stock Sentiment Analysis

Who this matters to: Sentiment Rank looks at the past five trading days. This is our shortest-term evaluation and is best used by people with a very short horizon.

Upgrade to Premium to unlock Stock Sentiment Ranking

Medifast Inc (MED) Analyst Forecast

MED Price, Volume, Earnings, and Dividend Date

  • Last Price $20.14
  • Previous Close $20.72
  • Change $-0.58
  • Open $20.71
  • Volume 456,443
  • Avg. Volume (100-day) 438,034
  • Market Cap 220,276,114
  • Days Range 19.87 - 20.83
  • 52-week Range 19.9 - 109.52
  • Dividend Yield 31.85%
  • Ex. Dividend Date 09/18/23
  • P-E 3.34
  • EPS 6.2
  • Earnings Date 08/05/24
  • Sector Consumer Cyclical
  • Industry Personal Services
  • Avg. Analyst Rec. Premium
  • Beta -2.283
  • PEG Ratio

Medifast Inc (MED) Company Description

Medifast Inc is a US-based company that produces, distributes and sells products concerning weight loss, weight management, and healthy living. The company generates its revenue from point of sale transactions executed over an e-commerce platform for weight loss, weight management, and other consumable health and nutritional products.

Medifast Inc (MED) Stock Chart